{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T22:21:52Z","timestamp":1788646912899,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030784","name":"UsAgainstAlzheimer's","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015595","name":"GHR Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008483","name":"NOMIS Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030010","name":"Arizona State Senate","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010292","name":"Banner Alzheimer's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG086363"],"award-info":[{"award-number":["R01 AG086363"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG072980"],"award-info":[{"award-number":["P30 AG072980"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG069453"],"award-info":[{"award-number":["R01 AG069453"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tjpad.2025.100334","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T19:48:03Z","timestamp":1755978483000},"page":"100334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A preliminary economic evaluation of a potential program for the primary prevention of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4666-9132","authenticated-orcid":false,"given":"Soeren","family":"Mattke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4119-4265","authenticated-orcid":false,"given":"Jiahe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tjpad.2025.100334_bib0001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s Disease","volume":"388","author":"Van","year":"2023","journal-title":"New England J Med"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100334_bib0002","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMa"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100334_bib0003","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1474-4422(23)00508-2","article-title":"A chance to prevent Alzheimer\u2019s disease sooner than you think","volume":"23","author":"Reiman","year":"2024","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100334_bib0004","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/1995-705X.95070","article-title":"Statins: past and present","volume":"12","author":"Hajar","year":"2011","journal-title":"Heart Views"},{"key":"10.1016\/j.tjpad.2025.100334_bib0005","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2024.23","article-title":"Health economic considerations in the deployment of an Alzheimer\u2019s prevention therapy","author":"Mattke","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100334_bib0006","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk Assessment, Genetic counseling, and Genetic testing for BRCA-related cancer: US preventive services task force recommendation statement","volume":"322","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2025.100334_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2025.0639","article-title":"The risk of Alzheimer disease in APOE4 homozygotes","author":"Reiman","year":"2025","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100334_bib0008","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.tjpad.2025.100334_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-024-00977-5","article-title":"Acceptable performance of blood biomarker tests of amyloid pathology \u2014 recommendations from the Global CEO Initiative on Alzheimer\u2019s disease","author":"Schindler","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100334_bib0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: mild cognitive impairment [RETIRED]","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100334_bib0011","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population: prevalence estimates using the 2000 census","volume":"60","author":"Hebert","year":"2003","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100334_bib0012","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jamaneurol.2021.5216","article-title":"Prevalence estimates of amyloid abnormality across the Alzheimer Disease clinical spectrum","volume":"79","author":"Jansen","year":"2022","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100334_bib0013","article-title":"Prevalence and risk of progression of preclinical Alzheimer\u2019s disease stages: a systematic review and meta-analysis. Alzheimer's research &","volume":"11","author":"Parnetti","year":"2019","journal-title":"Therapy"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100334_bib0014","article-title":"Disease progression modelling from preclinical Alzheimer\u2019s disease (AD) to AD dementia","volume":"11","author":"Cho","year":"2021","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100334_bib0016","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jamaneurol.2018.0629","article-title":"Prevalence and outcomes of amyloid positivity among persons without dementia in a longitudinal, population-based setting","volume":"75","author":"Roberts","year":"2018","journal-title":"JAMa Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100334_bib0017","doi-asserted-by":"crossref","first-page":"802","DOI":"10.14283\/jpad.2024.122","article-title":"Amyloid and tau prediction of cognitive and functional decline in unimpaired older individuals: longitudinal data from the A4 and LEARN studies","volume":"11","author":"Sperling","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100334_bib0018","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/CIRCOUTCOMES.116.002985","article-title":"Access to evidence-based statins in low-cost generic drug programs","volume":"9","author":"Jackevicius","year":"2016","journal-title":"Cardiovascul Qualit Outcom"},{"key":"10.1016\/j.tjpad.2025.100334_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12578","article-title":"Projecting the long-term societal value of a disease-modifying treatment for Alzheimer's disease in the United States","author":"Prados","year":"2022","journal-title":"Alzheimer' Dementia"},{"key":"10.1016\/j.tjpad.2025.100334_bib0020","article-title":"Expected wait times for access to a disease-modifying Alzheimer's treatment in the United States","author":"Mattke","year":"2021","journal-title":"Alzheimer' Dementia"},{"key":"10.1016\/j.tjpad.2025.100334_bib0022","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2024.81","article-title":"Medical costs and caregiver burden of delivering disease-modifying Alzheimer\u2019s treatments with different duration and route of administration","author":"Ozawa","year":"2024","journal-title":"J Prev Alzheimers Dis"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725002778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725002778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T05:42:57Z","timestamp":1786081377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725002778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2274580725002778"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100334","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A preliminary economic evaluation of a potential program for the primary prevention of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100334"}}